The American Journal of Managed Care

The American Journal of Managed Care The American Journal of Managed Care is a peer-reviewed, indexed publication. It has the #1 Impact Factor in the MC market.

Its accompanying website, AJMC.com, offers the latest news in health policy, disease states, and managed care. The American Journal of Managed Care is a peer-reviewed, indexed publication reaching over 48,500 MC executives.

Today, the approved depemokimab-ulaa (Exdensur; GSK) as an add-on maintenance therapy in patients aged 12 years and ol...
12/17/2025

Today, the approved depemokimab-ulaa (Exdensur; GSK) as an add-on maintenance therapy in patients aged 12 years and older with severe with an eosinophilic phenotype.

Learn more here: https://hubs.li/Q03Yt0ys0

12/17/2025

The newest ROS1+ NSCLC guideline update centers on the FDA’s approval of taletrectinib, supported by standout results from the TRUST-1 and TRUST-2 trials. With response rates nearing 88 percent in treatment-naive patients, this development represents a significant step forward in managing advanced metastatic ROS1-positive lung cancer.

Yesterday, the issued new guidance allowing de-identified real-world evidence ( ) in certain medical device applicatio...
12/16/2025

Yesterday, the issued new guidance allowing de-identified real-world evidence ( ) in certain medical device applications, removing a barrier to using large data sources.

Learn more here: https://hubs.li/Q03Yj5F50

12/16/2025

As we celebrate , we asked thought leaders: What role has AJMC® played in bridging the gap between research and practical application in the field of managed care?

Sophia Humphreys, PharmD, MHA, BCBBS, shares how AJMC connects “benchwork to bedside,” fostering collaboration that drives better outcomes across managed care.

How has AJMC impacted your work in the field? Comment below!

New findings from 2 abstracts presented at reveal T-DXd regimens enhance outcomes and tolerability for patients with h...
12/14/2025

New findings from 2 abstracts presented at reveal T-DXd regimens enhance outcomes and tolerability for patients with high-risk HER2-positive early .

Learn more here: https://hubs.li/Q03X-FSm0

Early counseling is necessary for young patients with before treatment limits options, said Yara Abdou, MD, at .Wat...
12/14/2025

Early counseling is necessary for young patients with before treatment limits options, said Yara Abdou, MD, at .

Watch here: https://hubs.li/Q03X-GSR0

Why are experts calling to “make LDL matter again”?In our recent Stakeholder Summit, experts look at what is still stand...
12/14/2025

Why are experts calling to “make LDL matter again”?

In our recent Stakeholder Summit, experts look at what is still standing in the way of better ASCVD management. They highlighted several challenges, including clinical inertia, low use of guideline-supported therapies, and barriers that prevent patients from getting the treatments they need.

Across every conversation, one theme stood out: lowering LDL early and consistently is key to reducing cardiovascular risk. Experts agreed that improving outcomes will require stronger coordination, better patient education, and policies that support evidence-based care.

Their insights show how much potential there is to close gaps and advance long-term heart health.
https://hubs.li/Q03X_JJB0

Treatment-induced can occur with severe symptoms, making personalized management and careful therapy selection essenti...
12/13/2025

Treatment-induced can occur with severe symptoms, making personalized management and careful therapy selection essential, according to experts at .

Learn more here: https://hubs.li/Q03X-FP-0

At , Amrita Basu, PhD, underscores that effective use for care depends on human oversight.Watch here: https://hubs....
12/13/2025

At , Amrita Basu, PhD, underscores that effective use for care depends on human oversight.

Watch here: https://hubs.li/Q03X-DV30

Experts at said alcohol consumption raises risk, emphasizing the need for public education and clinical intervention...
12/12/2025

Experts at said alcohol consumption raises risk, emphasizing the need for public education and clinical intervention.

Learn more here: https://hubs.li/Q03X-z-D0

associated with was mostly mild, nondisabling, and reversible, according to Adam Brufsky, MD, PhD, at .Watch here: ...
12/12/2025

associated with was mostly mild, nondisabling, and reversible, according to Adam Brufsky, MD, PhD, at .

Watch here: https://hubs.li/Q03X-Frv0

12/11/2025

Emerging data shows a more hopeful outlook to multiple myeloma treatment.

With modern 4-drug regimens and transplant already driving progression-free survival beyond 10 years, the next frontier is integrating powerful immunotherapies earlier in the disease course. In this clip, an expert explores how agents like linvoseltamab may shift treatment upstream, intercept smoldering disease, and harness the immune system to achieve deeper, longer-lasting control. The potential to push first-line PFS to 15 years or more could redefine what’s possible for patients.

Address

Plainsboro, NJ

Telephone

+16097167777

Website

https://linktr.ee/ajmcjournal

Alerts

Be the first to know and let us send you an email when The American Journal of Managed Care posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to The American Journal of Managed Care:

Shortcuts

Share

Category